Cargando…

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance

Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of “tuning” immune responses has recently been used to combat infectious diseases and cancer, and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Andorko, James I., Hess, Krystina L., Jewell, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365095/
https://www.ncbi.nlm.nih.gov/pubmed/25533221
http://dx.doi.org/10.1208/s12248-014-9708-2
_version_ 1782362181147295744
author Andorko, James I.
Hess, Krystina L.
Jewell, Christopher M.
author_facet Andorko, James I.
Hess, Krystina L.
Jewell, Christopher M.
author_sort Andorko, James I.
collection PubMed
description Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of “tuning” immune responses has recently been used to combat infectious diseases and cancer, and to induce tolerance during organ transplants or autoimmune disease. Lymph nodes and other secondary lymphoid organs such as the spleen play crucial roles in determining if and how these responses develop following vaccination or immunotherapy. Thus, by manipulating the local microenvironments within these immunological command centers, the nature of systemic immune response can be controlled. This review provides recent examples that harness the interactions between biomaterials and lymph nodes or other secondary lymphoid organs to generate immunity or promote tolerance. These strategies draw on mechanical properties, surface chemistry, stability, and targeting to alter the interactions of cells, signals, and vaccine components in lymph nodes. While there are still many unanswered questions surrounding how best to design biomaterial-based vaccines to promote specific structures or functions in lymph nodes, features such as controlled release and targeting will help pave the way for the next generation of vaccines and immunotherapies that generate immune responses tuned for specific applications.
format Online
Article
Text
id pubmed-4365095
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-43650952015-03-25 Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance Andorko, James I. Hess, Krystina L. Jewell, Christopher M. AAPS J Review Article Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of “tuning” immune responses has recently been used to combat infectious diseases and cancer, and to induce tolerance during organ transplants or autoimmune disease. Lymph nodes and other secondary lymphoid organs such as the spleen play crucial roles in determining if and how these responses develop following vaccination or immunotherapy. Thus, by manipulating the local microenvironments within these immunological command centers, the nature of systemic immune response can be controlled. This review provides recent examples that harness the interactions between biomaterials and lymph nodes or other secondary lymphoid organs to generate immunity or promote tolerance. These strategies draw on mechanical properties, surface chemistry, stability, and targeting to alter the interactions of cells, signals, and vaccine components in lymph nodes. While there are still many unanswered questions surrounding how best to design biomaterial-based vaccines to promote specific structures or functions in lymph nodes, features such as controlled release and targeting will help pave the way for the next generation of vaccines and immunotherapies that generate immune responses tuned for specific applications. Springer US 2014-12-23 /pmc/articles/PMC4365095/ /pubmed/25533221 http://dx.doi.org/10.1208/s12248-014-9708-2 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article
Andorko, James I.
Hess, Krystina L.
Jewell, Christopher M.
Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title_full Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title_fullStr Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title_full_unstemmed Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title_short Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
title_sort harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365095/
https://www.ncbi.nlm.nih.gov/pubmed/25533221
http://dx.doi.org/10.1208/s12248-014-9708-2
work_keys_str_mv AT andorkojamesi harnessingbiomaterialstoengineerthelymphnodemicroenvironmentforimmunityortolerance
AT hesskrystinal harnessingbiomaterialstoengineerthelymphnodemicroenvironmentforimmunityortolerance
AT jewellchristopherm harnessingbiomaterialstoengineerthelymphnodemicroenvironmentforimmunityortolerance